H&T Presspart has acquired novelex AG from Liberta Partners
novelex is an integral partner of the pharmaceutical industry worldwide. The company provides design, development, manufacturing, assembly and packaging services for custom medical and drug delivery solutions. The team consists of 100 employees across engineering, molding, assembly, logistics and quality segments. The company offers its customers safe and high-quality complete plastic solutions in the healthcare sector. novelex also has a reputation for the highest quality “made in Switzerland” and completely integrated service solutions required by the pharmaceutical and laboratory industry. Thereby, the company provides complete product development solutions from scratch. novelex produces over 38 million medical devices annually.
With the addition of novelex, H&T Presspart extends its focus and completely integrated product solution offerings for pharmaceutical clients. Christian Krätzig, President of H&T Presspart, commented, “novelex’s business is an excellent strategic fit. The acquisition will open up new opportunities to accelerate growth. novelex‘s extensive experience in the delivery of high-quality components and devices for pharmaceutical clients complements our offering and capabilities in the growing drug delivery device market.”
Lincoln International acted as exclusive mergers and acquisitions advisor for H&T Presspart, working closely with the shareholders and management throughout the process. This included providing strategic and tactical advisory expertise at critical moments during the due diligence and final phase of the process. The transaction adds to Lincoln International’s successful track record in the global healthcare space and demonstrates once more the firm’s proven buy-side expertise. Financial terms of the transaction were not disclosed.
About H&T Presspart
H&T Presspart is a market-leading manufacturer of drug delivery devices and components focusing on respiratory treatments, with over 50 years of experience. The company enjoys a worldwide reputation for competence, quality and innovation in the pharmaceutical market. H&T Presspart’s new product development center and inhalation product technology center support its customers’ new product developments and strategic initiatives. H&T Presspart has three European manufacturing sites and sales offices in China, India, the United States and Uruguay.
About Heitkamp & Thumann Group
Heitkamp & Thumann Group is a leading global partner for the supply of world-class precision-formed components in both metal and plastic. The family-owned group comprises of 14 medium-sized companies located in eight different countries. Efficiency, quality and innovation have always been at the very center of its corporate philosophy and entrepreneurial activities. Highly qualified and motivated employees and lean structures makes Heitkamp & Thumann successful all over the world.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners
Lincoln International is pleased to announce that Hg has agreed to make a strategic investment in HHAeXchange
Lincoln International is pleased to announce that Bridges Fund Management has sold The Vet to CVS Group plc
Lincoln is pleased to announce that Linsalata Capital Partners has sold Home Helpers to RiverGlade Capital
Lincoln International is pleased to announce the merger of Optovue with Luneau Technology
Lincoln International is pleased to announce that OPEN Health, a portfolio company of Amulet Capital Partners, has acquired Spirit Medical Communications
Lincoln International is pleased to announce that Frazier Healthcare Partners has refinanced Orthotic Holdings Inc.
Lincoln International is pleased to announce that it has advised Westbridge Capital on the sale of AJM Healthcare to Livingbridge